Angiogenic and inflammatory biomarkers in midpregnancy and small-for-gestational-age outcomes in Tanzania

American Journal of Obstetrics and Gynecology

Volumn 211, Issue 5, 2014, Pages 509.e1-509.e8

  Darling, Anne Marie ^a   McDonald, Chloe R ^b,c   Conroy, Andrea L ^b   Hayford, Kyla T ^b   Liles, W Conrad ^d   Wang, Molin ^a   Aboud, Said ^e   Urassa, Willy S ^e   Kain, Kevin C ^b,c   Fawzi, Wafaie W ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

angiogenesis; inflammation; small for gestational age

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN 3; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CELL PROTEIN; CHITINASE; CHITINASE 3 LIKE PROTEIN 1; COMPLEMENT COMPONENT C5A; COMPLEMENT FACTOR D; ENDOGLIN; INTERLEUKIN 1BETA; LEPTIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACENTAL GROWTH FACTOR; SOLUBLE INTERCELLULAR ADHESION MOLECULE; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; CELL SURFACE RECEPTOR; COMPLEMENT; CYTOKINE; ENG PROTEIN, HUMAN; FLT1 PROTEIN, HUMAN; INTERCELLULAR ADHESION MOLECULE 1; LEUKOCYTE ANTIGEN; PLACENTA PROTEIN; VEGFA PROTEIN, HUMAN;

ADULT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SMALL FOR DATE INFANT; TANZANIA; ADOLESCENT; ANGIOGENESIS; BLOOD; FIRST TRIMESTER PREGNANCY; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; METABOLISM; MULTIVARIATE ANALYSIS; NEWBORN; PHYSIOLOGY; PREGNANCY; REGRESSION ANALYSIS; SECOND TRIMESTER PREGNANCY; YOUNG ADULT;

ADOLESCENT; ADULT; ANGIOPOIETINS; ANTIGENS, CD; BIOMARKERS; BIRTH WEIGHT; C-REACTIVE PROTEIN; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LEPTIN; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REGRESSION ANALYSIS; TANZANIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; YOUNG ADULT;

EID: 84908317537     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.05.032     Document Type: Article

References (45)

1. A. Suhag, and V. Berghella Intrauterine growth restriction (IUGR): etiology and diagnosis Curr Obstet Gynecol Rep 2 2013 102 111
2. A.C. Lee, J. Katz, and H. Blencowe National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010 Lancet Global Health 1 2013 e26 e36
3. S. Longo, L. Bollani, L. Decembrino, A. Di Comite, M. Angelini, and M. Stronati Short-term and long-term sequelae in intrauterine growth retardation (IUGR) J Matern Fetal Neonatal Med 26 2013 222 225
4. R.K. Morris, E.A. Oliver, G. Malin, K.S. Khan, and C. Meads Effectiveness of interventions for the prevention of small-for-gestational age fetuses and perinatal mortality: a review of systematic reviews Acta Obstet Gynecol Scand 92 2013 143 151
5. A. Conde-Agudelo, A.T. Papageorghiou, S.H. Kennedy, and J. Villar Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta-analysis BJOG 120 2013 681 694
6. P. Kaufmann, T.M. Mayhew, and D.S. Charnock-Jones Aspects of human fetoplacental vasculogenesis and angiogenesis, II: changes during normal pregnancy Placenta 25 2004 114 126
7. R. Raghupathy, M. Al-Azemi, and F. Azizieh Intrauterine growth restriction: cytokine profiles of trophoblast antigen-stimulated maternal lymphocytes Clin Dev Immunol 2012 2012 734865
8. W.W. Fawzi, G.I. Msamanga, and W. Urassa Vitamins and perinatal outcomes among HIV-negative women in Tanzania N Engl J Med 356 2007 1423 1431
9. D. Watson-Jones, H.A. Weiss, and J.M. Changalucha Adverse birth outcomes in United Republic of Tanzania-impact and prevention of maternal risk factors Bull World Health Organ 85 2007 9 18
10. S.E. Maynard, T.A. Moore Simas, and M.J. Solitro Circulating angiogenic factors in singleton vs multiple-gestation pregnancies Am J Obstet Gynecol 198 2008 200.e1 200.e7
11. R.L. Berkowitz Multiple gestations S.G. Gabbe, J.R. Niebyl, J.L. Simpson, Obstetrics: normal and problem pregnancies 1986 Churchill Livingstone New York 739 767
12. W.E. Brenner, D.A. Edelman, and C.H. Hendricks A standard of fetal growth for the United States of America Am J Obstet Gynecol 126 1976 555 564
13. D. Spiegelman, and E. Hertzmark Easy SAS calculations for risk or prevalence ratios and differences Am J Epidemiol 162 2005 199 200
14. S. Durrleman, and R. Simon Flexible regression models with cubic splines Stat Med 8 1989 551 561
15. E. Geva, D.G. Ginzinger, C.J. Zaloudek, D.H. Moore, A. Byrne, and R.B. Jaffe Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2 J Clin Endocrinol Metab 87 2002 4213 4224
16. F. Crispi, C. Dominguez, E. Llurba, P. Martin-Gallan, L. Cabero, and E. Gratacos Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction Am J Obstet Gynecol 195 2006 201 207
17. L.C. Poon, E. Zaragoza, R. Akolekar, E. Anagnostopoulos, and K.H. Nicolaides Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation Prenat Diagn 28 2008 1110 1115
18. R.N. Taylor, J. Grimwood, R.S. Taylor, M.T. McMaster, S.J. Fisher, and R.A. North Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies Am J Obstet Gynecol 188 2003 177 182
19. R. Romero, J.K. Nien, and J. Espinoza A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate J Matern Fetal Neonatal Med 21 2008 9 23
20. N.J. Cowans, A. Stamatopoulou, E. Matwejew, C.S. von Kaisenberg, and K. Spencer First-trimester placental growth factor as a marker for hypertensive disorders and SGA Prenat Diagn 30 2010 565 570
21. S.J. Benton, Y. Hu, and F. Xie Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction? Am J Obstet Gynecol 206 2012 163.e1 163.e7
22. N.A. Bersinger, and R.A. Ødegard Serum levels of macrophage colony stimulating, vascular endothelial, and placenta growth factor in relation to later clinical onset of pre-eclampsia and a small-for gestational age birth Am J Reprod Immunol 54 2005 77 83
23. B.O. Åsvold, L.J. Vatten, P.R. Romundstad, P.A. Jenum, S.A. Karumanchi, and A. Eskild Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction Am J Epidemiol 173 2011 630 639
24. D. Borras, A. Perales-Puchalt, N. Ruiz Sacedon, and A. Perales Angiogenic growth factors in maternal and fetal serum in pregnancies complicated with intrauterine growth restriction J Obstet Gynaecol 34 2014 218 220
25. R. Trollman, K. Amann, and E. Schoof Hypoxia activates the human placental vascular endothelial growth factor system in vitro and in vivo: up-regulation of vascular endothelial growth factor in clinically relevant hypoxic ischemia in birth asphyxia Am J Obstet Gynecol 188 2003 517 523
26. R.L. Kendall, G. Wang, and K.A. Thomas Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR Biochem Biophys Res Commun 226 1996 324 328
27. G.J. Burton, D.S. Charnock-Jones, and E. Jauniaux Regulation of vascular growth and function in the human placenta Reproduction 138 2009 895 902
28. E. Shibata, A. Rajakumar, and R.W. Powers Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor J Clin Endocrinol Metab 90 2005 4895 4903
29. K.A. Wathén, E. Tuutti, and U.H. Stenman Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation J Clin Endocrinol Metab 91 2006 180 184
30. A. Rajakumar, A. Jeyabalan, N. Markovic, R. Ness, C. Gilmour, and K.P. Conrad Placental HIF-1 alpha, HIF-2 alpha, membrane and soluble VEGF receptor-1 proteins are not increased in normotensive pregnancies complicated by late-onset intrauterine growth restriction Am J Physiol Regul Integr Comp Physiol 293 2007 R766 R774
31. T. Chaiworapongsa, J. Espinoza, and F. Gotsch The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation J Matern Fetal Neonatal Med 21 2008 25 40
32. H. Stepan, T. Krämer, and R. Faber Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction J Clin Endocrinol Metab 92 2007 2831 2834
33. T. Boutsikou, A. Malamitsi-Puchner, E. Economou, M. Boutsikou, K.P. Puchner, and D. Hassiakos Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates Early Hum Dev 82 2006 235 239
34. W. Wallner, R. Sengenberger, and R. Strick Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction Clin Sci (Lond) 112 2007 51 57
35. A.L. Conroy, W.C. Liles, M.E. Molyneux, S.J. Rogerson, and K.C. Kain Performance characteristics of combinations of host biomarkers to identify women with occult placental malaria: a case-control study from Malawi PLoS One 6 2011 e28540
36. A.J. Umbers, E.H. Aitken, and S.J. Rogerson Malaria in pregnancy: small babies, big problem Trends Parasitol 27 2011 168 175
37. M.Y. Kim, C.W. Byeon, K.H. Hong, K.H. Han, and S. Jeong Inhibition of the angiogenesis by the MCP-1 (monocyte chemoattractant protein-1) binding peptide FEBS Lett 579 2005 1597 1601
38. R. Salcedo, M.L. Ponce, and H.A. Young Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression Blood 96 2000 34 40
39. K. Naruse, B.A. Innes, J.N. Bulmer, S.C. Robson, R.F. Searle, and G.E. Lash Secretion of cytokines by villous cytotrophoblast and extravillous trophoblast in the first trimester of human pregnancy J Reprod Immunol 86 2010 148 150
40. H.M. Georgiou, Y.S. Thio, and C. Russell Association between maternal serum cytokine profiles at 7-10 weeks' gestation and birthweight in small for gestational age infants Am J Obstet Gynecol 204 2011 415.e1 415.e12
41. D.D. Briana, M. Boutsikou, and S. Baka Perinatal plasma monocyte chemotactic protein-1 concentrations in intrauterine growth restriction Mediators Inflamm 2007 2007 65032
42. D.D. Briana, and A. Malamitsi-Puchner Reviews: adipocytokines in normal and complicated pregnancies Reprod Sci 16 2009 921 937
43. H. Mise, N. Sagawa, and T. Matsumoto Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia J Clin Endocrinol Metab 83 1998 3225 3229
44. K.J. Rothman No adjustments are needed for multiple comparisons Epidemiology 1 1990 43 46
45. R.L. Goldenberg, and S.P. Cliver Small for gestational age and intrauterine growth restriction: definitions and standards Clin Obstet Gynecol 40 1997 704 714